DXCM vs MDLN: stock comparison and AI forecast
Dexcom Inc (DXCM) and Medline Inc. (MDLN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
DXCM Dexcom Inc
- Price
- $82.29 +38.2% · 6M
- Market Cap
- $31.05B
- P/E Ratio
- 29.9x
- Size
- large-cap
- AI Forecast
- NO CURRENT FORECAST
MDLN Medline Inc.
- Price
- $33.63 -23.9% · 6M
- Market Cap
- $44.21B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- MDLN is 1.4 times larger than DXCM by market capitalization ($44.21B against $31.05B).
- Over the last six months DXCM returned +38.2% and MDLN -23.9%.
- MDLN carries 1.75 times debt per unit of equity, against 1.46 times for DXCM.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | DXCM | MDLN |
|---|---|---|
| Market Cap | $31.05B | $44.21B |
| P/E Ratio | 29.92x | – |
| P/B Ratio | 12.25x | 3.82x |
| EPS | $2.75 | – |
| Book Value/Share | $6.72 | $8.80 |
| Revenue/Share | $13.53 | – |
| FCF/Share | $2.91 | – |
Profitability & Margins
| Metric | DXCM | MDLN |
|---|---|---|
| ROE | 39.1% | – |
| ROA | 15.9% | – |
| ROIC | 30.7% | – |
| Gross Margin | 63.4% | – |
| Operating Margin | 24.0% | – |
| Net Margin | 19.4% | – |
| EBT Margin | 24.7% | – |
| Tax Rate | 21.5% | – |
Financial Health
| Metric | DXCM | MDLN |
|---|---|---|
| Current Ratio | 1.74x | 4.33x |
| Quick Ratio | 1.40x | 2.61x |
| D/E Ratio | 1.46x | 1.75x |
| Financial Leverage | 2.46x | 3.40x |
| Interest Coverage | 155.8x | 1.5x |
| Working Capital | $1.66B | $9.03B |
Cash Flow
| Metric | DXCM | MDLN |
|---|---|---|
| Operating Cash Flow | $1.41B | – |
| Free Cash Flow | $1.10B | – |
| Capital Spending | -$316M | – |
| OCF Growth YoY | -2.3% | – |
| FCF Growth YoY | 3.4% | – |
| FCF/Sales | 21.5% | – |
| CapEx/Sales | 6.2% | – |
Operational Efficiency
| Metric | DXCM | MDLN |
|---|---|---|
| Asset Turnover | 0.82x | – |
| Receivables Turnover | 4.3x | – |
| Inventory Turnover | 2.4x | – |
| Fixed Assets Turnover | 3.3x | – |
| Days Sales Outstanding | 85 days | – |
| Days Inventory | 151 days | – |
| Payables Period | 404 days | – |
| Cash Conversion Cycle | -168 days | – |
Income Statement
| Metric | DXCM | MDLN |
|---|---|---|
| Total Revenue | $5.10B | – |
| Operating Income | $1.22B | – |
| Net Income | $991M | – |
| R&D Expense | $608M | – |
| SG&A Expense | $1.41B | – |
| Cost of Goods Sold | $1.87B | – |
Dividend & Shareholder Information
| Metric | DXCM | MDLN |
|---|---|---|
| Shares Outstanding | 377M | 1315M |
| Net Income Growth | 37.5% | – |
| EPS Growth | 54.5% | – |
DXCM vs MDLN: stock comparison and AI forecast
Which is bigger, DXCM or MDLN?
MDLN is 1.4 times larger than DXCM by market capitalization ($44.21B against $31.05B).
Which stock performed better over the last six months, DXCM or MDLN?
Over the last six months DXCM returned +38.2% and MDLN -23.9%.
Which one does Intratio's AI model rank higher, DXCM or MDLN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.